Beijing Health (Holdings) Limited (Beijing Health) reported unanimous shareholder support at its 2 June 2026 annual general meeting. All ten resolutions—nine ordinary and one special—were passed with 100.00% of votes cast in favour.

Key voting statistics • Voting participation: 2.62 billion shares, equal to 43.19% of the 6.06 billion shares in issue. • Opposition votes: None recorded across any resolution. • Scrutineer: Union Registrars Limited oversaw the poll count.

Board and governance decisions • Financial statements for FY 2025 were adopted. • Executive directors Mr. Gu Shan Chao and Mr. Wang Zheng Chun, along with independent non-executive director Mr. Zhang Yun Zhou, were re-elected. • The board (or its remuneration committee) received authority to set directors’ remuneration. • Ernst & Young was re-appointed as external auditor for FY 2026, with the board authorised to fix fees.

Capital management mandates • Share buyback: Directors may repurchase up to 10% of issued shares (excluding any treasury shares). • Share issuance: Directors may allot, issue, deal with or sell treasury shares up to 20% of issued share capital, with an additional mandate to extend this limit by the number of shares repurchased.

Constitutional update A special resolution to adopt a further amended and restated memorandum and articles of association garnered 100.00% support, comfortably surpassing the 75% threshold.

Attendance and board presence All four executive directors and all four independent non-executive directors attended the AGM, either in person or electronically.

The complete adoption of every resolution—with no votes against—confirms broad shareholder endorsement of Beijing Health’s current governance, capital management strategy and revised constitutional documents.